Norway
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 93.79 M
|
Dec. 31, 2024 | USD 17.55 | -0.93% |
|
Norway |
|
2 |
USD 4.74 M
|
Dec. 31, 2023 | USD 5.15 | 1.58% |
|
Norway |
|
3 |
USD 2.40 M
|
Dec. 31, 2023 | USD 1.29 | 3.46% |
|
Norway |
|
4 |
USD 1.52 M
|
Dec. 31, 2023 | USD 4.11 | 5.18% |
|
Norway |
|
5 |
USD 271.06 K
|
Dec. 31, 2023 | USD 0.26 | -0.50% |
|
Norway |
|
6 |
USD 213.92 K
|
Dec. 31, 2023 | USD 2.23 | 3.92% |
|
Norway |
|
7 |
USD -3.53 M
|
Dec. 31, 2023 | USD 1.16 | 3.36% |
|
Norway |
|
8 |
USD -6.29 M
|
Dec. 31, 2023 | USD 0.22 | -1.39% |
|
Norway |
|
9 |
USD -18.64 M
|
Dec. 31, 2023 | USD 0.19 | 1.62% |
|
Norway |
|
10 |
USD -22.10 M
|
Dec. 31, 2023 | USD 0.71 | -1.42% |
|
Norway |
|
11 |
USD -96.62 M
|
Dec. 31, 2023 | USD 0.23 | 0.18% |
|
Norway |
The Biotechnology company in Norway with the highest Operating Cash Flow is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at USD 93.79 M.
The Biotechnology company in Norway with the lowest Operating Cash Flow is Nykode Therapeutics AS (Oslo Stock Exchange: NYKD.OL) at USD -96.62 M.
The top 10 Biotechnology companies in Norway by Operating Cash Flow are Borregaard ASA, Photocure ASA, ArcticZymes Technologies ASA, Gentian Diagnostics ASA, Hofseth BioCare ASA, Navamedic ASA, Lifecare AS, Thor Medical ASA, Ultimovacs ASA and BerGenBio ASA.
The bottom 10 Biotechnology companies in Norway by Operating Cash Flow are Nykode Therapeutics AS, BerGenBio ASA, Ultimovacs ASA, Thor Medical ASA, Lifecare AS, Navamedic ASA, Hofseth BioCare ASA, Gentian Diagnostics ASA, ArcticZymes Technologies ASA and Photocure ASA.